Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2453 posts found.

mark_greener_21

Mark Greener appointed editorial director at Rock Medical Communications

November 14, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mark Greener, Rock Medical Communications

Rock medical communications has appointed journalist and medical writer Mark Greener as editorial director.  Mark spent a decade in the …

The ABPI’s new leader: communicating pharma’s value

November 14, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Stephen Whitehead

When Richard Barker, the ABPI’s director general decided to step down in May this year after six and a half …

Genzyme appoints new leaders for multiple sclerosis and rare disease businesses

November 14, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genzyme

Genzyme, a Sanofi company, has appointed William Sibold as head of multiple sclerosis and Rogério Vivaldi as head of rare …

Timothy Wright appointed as global head of development at Novartis Pharmaceuticals

November 9, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis

Novartis has appointed Dr Timothy Wright as the new global head of development of its pharmaceuticals business, effective immediately.  Dr …

Edge Medical Communications makes two senior appointments

November 9, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Edge Medical, Medical comms

Edge Medical Communications has appointed Dr Laurence De-Netto as account director and Dr Elizabeth Rapley as business development manager. Dr …

Strategic alliance executives

November 8, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CTPartners, Strategic alliance executives

Given the extraordinary costs and risks associated with drug discovery and development, it’s not surprising that an increasing number of …

Daniel Grau appointed as president of Heptares

November 8, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daniel Grau, Heptares

Daniel Grau has been appointed as president of Heptares Therapeutics, a specialist in G-protein-coupled receptors.  Mr Grau has been a …
david_roblin__picture_o

Ex-Pfizer R&D head Dr David Roblin joins Destiny Pharma

November 7, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Destiny Pharma, Pfizer, R&D

Anti-microbial drug developers Destiny Pharma have appointed Dr David Roblin as its new medical director. Dr Roblin was formerly head …
steve_hobbsrgb

Steve Hobbs joins Apodi senior management team

November 4, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Steve Hobbs has joined Apodi’s senior management team as director of business and account development. Steve has over 30 years …

Graham Higson joins NDA Group to lead Regulatory and HTA Advisory Board

November 4, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA

GE Healthcare and ex AstraZeneca Head of Global Regulatory Affairs, Graham Higson, will join NDA Group in January 2012 to …

Synergy Vision hires Caroline Loder and Natalie Ferguson

November 3, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Synergy Vision

Synergy Vision, the London-based medical communications agency, has hired Caroline Loder as a senior medical writer and Natalie Ferguson as a …
e

Teva sees modest growth as US sales fall

November 3, 2011 Business Services, Sales and Marketing Teva, generics

Sales growth at Teva was modest in Q3, rising 2% to $4.34 billion, with growth predominately coming from branded drugs.This …

Richard Daniell appointed as managing director of Teva UK

November 2, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Teva Pharmaceutical

Richard Daniell has been appointed as managing director for Teva UK, and will be responsible for all Teva’s commercial activities …
Helen Tayton-Martin

Working Life: Adaptimmune’s Helen Tayton-Martin

October 31, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Working Life

Helen Tayton-Martin who is an executive director at Adaptimmune, talks to Pharmafocus about her role and working in cell therapy. …
GSK logo

GSK sees strong Q3 after battling headwinds

October 27, 2011 Business Services, Sales and Marketing GSK, GSK. Q3, Q3

GlaxoSmithKline has posted a set of healthy figures for the third quarter, underlying its return to growth after a tough …
The Gateway to Local Adoption Series

Latest content